IRIDEX Corp
IRIX1.190USD
-0.090-7.03%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
20.01MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über IRIDEX Corp Unternehmen
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Unternehmensinformationen
BörsenkürzelIRIX
Name des UnternehmensIRIDEX Corp
IPO-datumFeb 16, 1996
CEOMr. Patrick Mercer
Anzahl der mitarbeiter93
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 16
Addresse1212 Terra Bella Ave
StadtMOUNTAIN VIEW
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl94043
Telefon16509404700
Websitehttps://www.iridex.com/
BörsenkürzelIRIX
IPO-datumFeb 16, 1996
CEOMr. Patrick Mercer
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
300.00K
+4.18%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
123.99K
+31.05%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
68.55K
+16.24%
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
300.00K
+4.18%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
123.99K
+31.05%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
68.55K
+16.24%
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Retina
6.64M
55.86%
G6
3.18M
26.74%
Other
2.07M
17.40%
Nach RegionUSD
Name
Umsatz
Anteil
United States
5.28M
44.41%
Asia/Pacific Rim
3.36M
28.24%
Europe & Middle East & Africa
2.86M
24.05%
Rest of the Americas
392.00K
3.30%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Retina
6.64M
55.86%
G6
3.18M
26.74%
Other
2.07M
17.40%
Aktionärsstatistik
Aktualisiert: Fri, Aug 29
Aktualisiert: Fri, Aug 29
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Topcon Corp
9.52%
Stanley Manne Trust
6.31%
Paragon JV Partners, LLC
5.88%
The Vanguard Group, Inc.
3.45%
Roland (Brent Alexander)
2.72%
Andere
72.12%
Aktionäre
Aktionäre
Anteil
Topcon Corp
9.52%
Stanley Manne Trust
6.31%
Paragon JV Partners, LLC
5.88%
The Vanguard Group, Inc.
3.45%
Roland (Brent Alexander)
2.72%
Andere
72.12%
Aktionärstypen
Aktionäre
Anteil
Corporation
17.91%
Individual Investor
10.13%
Hedge Fund
9.45%
Investment Advisor
4.86%
Investment Advisor/Hedge Fund
1.36%
Venture Capital
0.15%
Andere
56.13%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
62
7.58M
45.15%
+346.62K
2025Q1
57
6.59M
39.89%
-547.85K
2024Q4
56
6.67M
40.12%
-576.91K
2024Q3
56
6.58M
39.55%
-791.78K
2024Q2
63
7.41M
45.29%
-103.92K
2024Q1
64
7.34M
45.55%
+258.49K
2023Q4
68
7.28M
45.21%
-25.53K
2023Q3
68
7.58M
47.03%
+345.93K
2023Q2
71
7.91M
49.44%
+523.96K
2023Q1
78
8.45M
52.97%
-216.41K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Topcon Corp
1.62M
9.64%
+6.00K
+0.37%
Apr 01, 2025
Stanley Manne Trust
1.07M
6.39%
--
--
Apr 01, 2025
Paragon JV Partners, LLC
1.00M
5.96%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
594.79K
3.54%
+33.69K
+6.00%
Mar 31, 2025
Roland (Brent Alexander)
461.71K
2.75%
+461.71K
--
Apr 01, 2025
Renaissance Technologies LLC
379.16K
2.26%
-2.00K
-0.52%
Mar 31, 2025
Moore (William M)
287.98K
1.72%
+50.00K
+21.01%
Jun 13, 2025
Roland Family Support Trust
223.69K
1.33%
+223.69K
--
Apr 01, 2025
AMH Equity, Ltd.
518.54K
3.09%
+17.42K
+3.48%
Mar 31, 2025
Roland (Glenn Cuthbert)
181.60K
1.08%
+181.60K
--
Apr 01, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
